Sex differences in zonulin in affective disorders and associations with current mood symptoms
Alexander Maget, Nina Dalkner, Carlo Hamm, S. Bengesser, F.T. Fellendorf, Martina Platzer, Robert Queissner, Armin Birner, Melanie Lenger, Sabrina Mörkl, Alexandra Kohlhammer-Dohr, Alexandra Rieger, M. D. Seidl, Lilli Mendel, Tanja Färber, Lisa‐Christin Wetzlmair, Karin Schwalsberger, DV Amberger-Otti, Helmut Schöggl, Theresa Lahousen, Birgitta Leitner-Afschar, Renate Unterweger, Sieglinde Zelzer, Harald Mangge, EZ Reininghaus
Abstract
INTRODUCTION: The bidirectional connection between the brain and the gut within psychiatric entities has gained increasing scientific attention over the last years. As a regulator of intestinal permeability, zonulin acts as a key player on the interface of this interplay. Like several psychiatric disorders, intestinal permeability was associated with inflammation in previous findings. METHODS: In this study we explored differences in zonulin serum levels in currently depressed (n = 55) versus currently euthymic (n = 37) individuals with an affective disorder. Further, we explored sex differences and possible influences on zonulin and affective symptoms like medication, age, body mass index, and smoking status. RESULTS: Serum zonulin was significantly higher in females than in men independent from affective status (z = -2.412, p = .016). More specifically, females in the euthymic subgroup had higher zonulin levels than euthymic men (z = -2.114, p = .035). There was no difference in zonulin serum levels in individuals taking or not taking a specific psychopharmacotherapy. We found no correlation between zonulin serum levels and depression severity. DISCUSSION: Increased serum zonulin levels as a proxy for increased intestinal permeability in women may indicate a state of elevated susceptibility for depression-inducing stimuli.